Vita Life Sciences Limited (ASX:VLS)
2.520
-0.080 (-3.08%)
At close: Mar 4, 2026
Vita Life Sciences Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 35.56 | 28.6 | 24.63 | 15.69 | 15.89 |
Cash & Short-Term Investments | 35.56 | 28.6 | 24.63 | 15.69 | 15.89 |
Cash Growth | 24.34% | 16.12% | 57.00% | -1.29% | 9.78% |
Accounts Receivable | 13.19 | 11.71 | 10.7 | 8.65 | 6.83 |
Other Receivables | 0.45 | 0.29 | 0.51 | 0.33 | 0.28 |
Receivables | 13.64 | 12 | 11.22 | 8.98 | 7.12 |
Inventory | 15.08 | 16.6 | 11.15 | 15.41 | 11.31 |
Prepaid Expenses | 0.68 | 0.77 | 0.59 | 0.61 | 0.48 |
Other Current Assets | 0.88 | 0.93 | 0.7 | 0.47 | 0.31 |
Total Current Assets | 65.85 | 58.9 | 48.29 | 41.16 | 35.1 |
Property, Plant & Equipment | 12.48 | 10.33 | 9.17 | 8.47 | 8.26 |
Other Intangible Assets | 0.04 | 0.05 | 0.03 | 0.01 | - |
Long-Term Deferred Tax Assets | 4 | 2.62 | 2.32 | 2.16 | 1.9 |
Total Assets | 82.36 | 71.89 | 59.81 | 51.8 | 45.27 |
Accounts Payable | 6.73 | 5.58 | 5.58 | 4.5 | 3.82 |
Accrued Expenses | 3.55 | 2.83 | 2.31 | 2.02 | 2.15 |
Current Portion of Leases | 0.48 | 0.3 | 0.21 | 0.3 | 0.19 |
Current Income Taxes Payable | 1.62 | 0.58 | 0.07 | 0.04 | 0.97 |
Other Current Liabilities | 11.79 | 9.99 | 8.05 | 8.01 | 7.34 |
Total Current Liabilities | 24.17 | 19.27 | 16.22 | 14.86 | 14.46 |
Long-Term Leases | 1.91 | 0.21 | 0.18 | 0.3 | 0.18 |
Pension & Post-Retirement Benefits | 0.13 | 0.12 | 0.08 | 0.14 | 0.13 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.07 |
Total Liabilities | 26.2 | 19.61 | 16.48 | 15.3 | 14.85 |
Common Stock | 42.79 | 45.03 | 42.57 | 41.9 | 41.63 |
Retained Earnings | 5.2 | 0.85 | -2.77 | -8.48 | -12.53 |
Comprehensive Income & Other | 8.26 | 6.48 | 3.6 | 3.15 | 1.65 |
Total Common Equity | 56.25 | 52.35 | 43.4 | 36.57 | 30.75 |
Minority Interest | -0.09 | -0.07 | -0.07 | -0.07 | -0.33 |
Shareholders' Equity | 56.16 | 52.28 | 43.33 | 36.5 | 30.42 |
Total Liabilities & Equity | 82.36 | 71.89 | 59.81 | 51.8 | 45.27 |
Total Debt | 2.39 | 0.52 | 0.39 | 0.6 | 0.37 |
Net Cash (Debt) | 33.17 | 28.08 | 24.24 | 15.09 | 15.52 |
Net Cash Growth | 18.11% | 15.84% | 60.69% | -2.79% | 25.11% |
Net Cash Per Share | 0.58 | 0.50 | 0.44 | 0.28 | 0.29 |
Filing Date Shares Outstanding | 55.5 | 56.56 | 56.4 | 56.53 | 55.19 |
Total Common Shares Outstanding | 55.5 | 56.56 | 56.4 | 56.53 | 55.19 |
Working Capital | 41.68 | 39.62 | 32.07 | 26.3 | 20.64 |
Book Value Per Share | 1.01 | 0.93 | 0.77 | 0.65 | 0.56 |
Tangible Book Value | 56.22 | 52.3 | 43.37 | 36.56 | 30.75 |
Tangible Book Value Per Share | 1.01 | 0.92 | 0.77 | 0.65 | 0.56 |
Land | 9.84 | 9.62 | 8.51 | 7.93 | 7.83 |
Machinery | 2.83 | 2.26 | 1.88 | 1.83 | 1.99 |
Construction In Progress | - | - | 0.48 | - | - |
Leasehold Improvements | 0.3 | 0.3 | 0.12 | 0.13 | 0.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.